Search

Now showing items 1-5 of 5

hMSH2 and hMLH1 gene expression patterns differ between lung adenocarcinoma and squamous cell carcinoma: correlation with patient survival and response to adjuvant chemotherapy treatment

Vageli, D. P.; Zaravinos, A.; Daniil, Z.; Dahabreh, J.; Doukas, S. G.; Spandidos, D. A.; Gourgoulianis, K. I.; Koukoulis, G. K. (2012)

Background: We recently showed that the mRNA levels of mismatch repair (MMR) proteins in non-small cell lung carcinoma (NSCLC) tissue specimens and the phenotypic translation of molecular MMR data refines the biology of ...

Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas

Vageli, D.; Daniil, Z.; Dahabreh, J.; Karagianni, E.; Vamvakopoulou, D. N.; Ioannou, M. G.; Scarpinato, K.; Vamvakopoulos, N. C.; Gourgoulianis, K. I.; Koukoulis, G. K. (2009)

Background: Defects in the human DNA mismatch repair genes (MMR) hMSH2 and hMLH1 arc responsible for the development of sporadic and hereditary colorectal cancers. The role of MMR genes in the pathogenesis of lung cancer ...

Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas (vol 64, pg 282, 2009)

Vageli, D.; Daniil, Z.; Dahabreh, J.; Karagianni, E.; Vamvakopoulou, D. N.; Ioannou, M. G.; Scarpinato, K.; Vamvakopoulos, N. C.; Gourgoulianis, K. I.; Koukoulis, G. K. (2010)

Indoleamine 2,3-dioxygenose (IDO) expression in lung cancer

Karanikas, V.; Zamanakou, M.; Kerenid, T.; Dahabreh, J.; Hevas, A.; Nakou, M.; Gourgoulianis, K. I.; Germenis, A. E. (2007)

Background: The expression of indoleamine 2,3-dioxygenase (IDO) by tumor cells has been considered as a major tumor immune escape mechanism. The aim of this study was to investigate the expression of IDO in lung cancer ...

Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer

Karanikas, V.; Zamanakou, M.; Kerenidi, T.; Dahabreh, J.; Hevas, A.; Nakou, M.; Gourgoulianis, K. I.; Germenis, A. E. (2007)